Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection: EXTEND study subgroup analyses

Podobne zapisy

• 1982. Multiplex PCR-Based Analysis of Enteric Pathogens in Faecal Samples from Patients with Clostridium difficile Infection in the Randomized, Controlled EXTEND Study Comparing the Efficacy of Extended-Pulsed Fidaxomicin With Vancomycin Therapy
  od: Wilcox, Mark, i wsp.
  Wydane: (2018)
• 1952. Evaluation of Relapse and Reinfection Using Whole-Genome Sequencing of Clostridium difficile Isolates From Elderly Patients With C. difficile Infection (CDI) in the EXTEND Randomized, Controlled, Comparative Study of Extended-Pulsed Fidaxomicin and Vancomycin for the Treatment of CDI
  od: Wilcox, Mark, i wsp.
  Wydane: (2018)
• Microbiological Characterization and Clinical Outcomes After Extended-Pulsed Fidaxomicin Treatment for Clostridioides difficile Infection in the EXTEND Study
  od: Wilcox, Mark H, i wsp.
  Wydane: (2019)
• Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged ≥60 years (EXTEND): analysis of cost-effectiveness
  od: Cornely, Oliver A, i wsp.
  Wydane: (2018)
• Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin
  od: Cornely, Oliver A., i wsp.
  Wydane: (2012)